hwa 138 has been researched along with Shock, Septic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birg, A; Frank, G; Hoffmann, H; Jochum, M; Schönharting, MM; Weis, M | 1 |
| Gunning, K; Masouyé, P; Morel, DR; Pittet, JF; Suter, PM | 1 |
2 other study(ies) available for hwa 138 and Shock, Septic
| Article | Year |
|---|---|
Amelioration of endotoxin-induced acute lung injury in pigs by HWA 138 and A 80 2715: new analogs of pentoxifylline.
Topics: Animals; Bronchodilator Agents; Hemodynamics; Infusions, Intravenous; Leukocyte Count; Leukopenia; Lipopolysaccharides; Pentoxifylline; Pulmonary Circulation; Respiratory Distress Syndrome; Shock, Septic; Swine; Swine, Miniature; Xanthines | 1995 |
Xanthine derivative HWA 138 attenuates hemodynamic and oxygen uptake dysfunction secondary to severe endotoxin shock in sheep.
Topics: Animals; Disease Models, Animal; Endotoxins; Escherichia coli; Female; Half-Life; Hemodynamics; Male; Oxygen Consumption; Pentoxifylline; Sheep; Shock, Septic | 1992 |